{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.28",
    "chg": -0.02,
    "chgp": "-0.87%",
    "dir": -1,
    "prev_price": "2.30",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 67,
    "isin": "INE984E01035",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "00:14 AM",
    "bse_nse_vol": "18.77 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivanza Biosciences Ltd Experiences Notable Gains Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-rises-4-59-today-marking-third-consecutive-day-of-gains-1693519",
        "imagepath": "",
        "date": "2025-04-03 09:40:13",
        "description": "Vivanza Biosciences Ltd is currently witnessing significant buying activity, with the stock gaining 4.59% today, contrasting sharply with the Sensex, which has declined by 0.38%. Over the past week, Vivanza has shown a robust performance, rising 12.32%, while the Sensex has fallen by 1.64%. Notably, the stock has experienced consecutive gains over the last three days, accumulating a total return of 14.57%.\n\nDespite this recent uptick, Vivanza's longer-term performance reveals challenges, with a 68.46% decline over the past year and a staggering 87.91% drop over three years. However, the stock has shown resilience over a five-year period, with a 74.05% increase, albeit underperforming the Sensex's 176.65% gain.\n\nToday's trading session opened with a gap up, and the intraday high reflects the strong buying momentum. The stock's current price is above its 5-day and 20-day moving averages, indicating short-term..."
      },
      {
        "title": "Vivanza Biosciences Ltd Sees Notable Buying Activity Amidst Mixed Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-surges-4-81-today-marking-8-04-gain-over-two-days-1674357",
        "imagepath": "",
        "date": "2025-04-02 11:15:07",
        "description": "Vivanza Biosciences Ltd is currently witnessing significant buying activity, with the stock rising by 4.81% today, outperforming the Sensex, which gained only 0.64%. Over the past two days, Vivanza has recorded consecutive gains totaling 8.04%. Despite this recent uptick, the stock has faced challenges over longer periods, with a 1-month decline of 13.49% compared to the Sensex's 4.53% increase.\n\nThe stock opened with a gap up, indicating strong initial buyer interest, and has shown resilience against broader market trends. While it remains above its 5-day moving average, it is still below the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a mixed performance in the context of longer-term trends.\n\nFactors contributing to the current buying pressure may include market sentiment shifts, potential news related to the company, or sector-specific developments. However, it is essential to note t..."
      },
      {
        "title": "Vivanza Biosciences Faces Challenges Amid Significant Stock Decline and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-52-week-low-amid-declining-sales-and-weak-financials-1660770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/VivanzaBioscien_priceRelatedfactors_852835.png",
        "date": "2025-04-01 11:48:27",
        "description": "Vivanza Biosciences has reached a new 52-week low, continuing a six-day losing streak. The stock has underperformed significantly over the past year, with a 70.75% decline. Financial metrics indicate weak fundamentals, including low ROCE and high debt levels, alongside a notable reduction in promoter stake."
      },
      {
        "title": "Vivanza Biosciences Hits 52-Week Low Amid Ongoing Financial Challenges and Stakeholder Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-52-week-low-amid-significant-decline-in-performance-and-stake-reduction-1660764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/VivanzaBioscien_priceRelatedfactors_852837.png",
        "date": "2025-04-01 11:48:25",
        "description": "Vivanza Biosciences has reached a new 52-week low, reflecting a substantial decline over the past year. The company faces ongoing financial challenges, including negative net sales growth and a high debt-to-EBITDA ratio. Additionally, promoter confidence has decreased, indicating concerns about its market position and financial health."
      },
      {
        "title": "Vivanza Biosciences Ltd Sees Notable Buying Activity Amidst Recent Price Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-surges-4-52-today-despite-70-75-yearly-decline-and-52-week-low-1660190",
        "imagepath": "",
        "date": "2025-04-01 11:45:07",
        "description": "Vivanza Biosciences Ltd is currently witnessing significant buying activity, marking a notable performance shift after a series of declines. Today, the stock has increased by 4.52%, contrasting sharply with the Sensex, which has declined by 1.56%. This uptick comes after six consecutive days of falling prices, indicating a potential trend reversal.\n\nDespite this daily gain, Vivanza's performance over the past week shows a slight decline of 1.42%, while the Sensex has decreased by 2.32%. Over the past month, Vivanza has faced a more substantial drop of 17.46%, compared to the Sensex's increase of 4.11%. The stock has reached a new 52-week low of Rs. 1.9 today, highlighting the volatility in its recent performance.\n\nThe buying pressure may be attributed to various factors, including market sentiment and potential interest in microcap stocks. However, Vivanza remains below its 5-day, 20-day, 50-day, 100-day, a..."
      },
      {
        "title": "Vivanza Biosciences Hits All-Time Low Amidst Ongoing Financial Challenges and Declining Stakeholder Confidence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-stock-hits-all-time-low-at-rs-1-9-amid-ongoing-challenges-1660168",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/VivanzaBioscien_priceRelatedfactors_852403.png",
        "date": "2025-04-01 11:41:24",
        "description": "Vivanza Biosciences has reached a new 52-week low, despite a recent performance uptick. The stock has declined significantly over the past year, underperforming the market. Financial metrics indicate weak fundamentals, and promoter confidence is waning, with a notable reduction in stake ownership, highlighting ongoing challenges for the company."
      },
      {
        "title": "Vivanza Biosciences Faces Major Financial Challenges Amidst Declining Stakeholder Confidence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-52-week-low-stock-declines-70-69-over-past-year-1641121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VivanzaBioscien_priceRelatedfactors_834376.png",
        "date": "2025-03-28 10:36:58",
        "description": "Vivanza Biosciences has faced considerable volatility, reaching a new 52-week low and experiencing a notable decline over the past four days. The company reported a significant drop in net sales and a low return on capital employed, alongside a concerning debt-to-EBITDA ratio. Promoter stake has also decreased, indicating waning confidence."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-significant-selling-pressure-declines-1-97-amid-70-69-yearly-loss-1641010",
        "imagepath": "",
        "date": "2025-03-28 10:35:15",
        "description": "Vivanza Biosciences Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past four days, resulting in a total loss of 7.44% during this period. Today, the stock fell by 1.97%, underperforming the Sensex, which saw a marginal increase of 0.01%.\n\nOver the past month, Vivanza Biosciences has recorded a staggering decline of 21.03%, while the Sensex gained 6.04%. The stock's performance has been consistently negative, with a year-to-date drop of 42.82% compared to the Sensex's slight decline of 0.67%. Notably, the stock has reached a new 52-week low of Rs. 1.99 today.\n\nThe ongoing selling pressure may be attributed to various factors, including the stock's underperformance relative to the broader market and its trading position below key moving averages across multiple timeframes. Over the last three years, Vi..."
      },
      {
        "title": "Vivanza Biosciences Hits All-Time Low Amid Ongoing Financial Struggles and Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-stock-hits-all-time-low-of-rs-1-99-amid-declining-performance-1641143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VivanzaBioscien_priceRelatedfactors_834365.png",
        "date": "2025-03-28 10:31:12",
        "description": "Vivanza Biosciences has faced notable volatility, hitting an all-time low and underperforming its sector. The stock has consistently declined over the past four days and is trading below key moving averages. Weak fundamentals and a significant reduction in promoter stake further highlight the company's challenges in the current market."
      }
    ],
    "total": 66,
    "sid": "515837",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2025",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 31st March 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Apr-2025",
      "details": "In compliance with Reg. 74(5) of SEBI(Depositories and Participants) Regulations 2018 we are enclosing herewith a copy of certificate received from Purva Sharegistry (India) Private Limited Registrar and Transfer Agent of the Company dated April 01 2025 for the quarter ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Mar-2025",
      "details": "The trading window for dealing in the equity shares of the Company shall remain closed for all designated persons and their immediate relatives from 1st April 2025 till 48 hours after the declaration of Audited Financial results of the Company for the quarter and year ended 31st March 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivanza Biosciences Ltd Experiences Notable Gains Amid Broader Market Decline

2025-04-03 09:40:13

Vivanza Biosciences Ltd is currently witnessing significant buying activity, with the stock gaining 4.59% today, contrasting sharply with the Sensex, which has declined by 0.38%. Over the past week, Vivanza has shown a robust performance, rising 12.32%, while the Sensex has fallen by 1.64%. Notably, the stock has experienced consecutive gains over the last three days, accumulating a total return of 14.57%. Despite this recent uptick, Vivanza's longer-term performance reveals challenges, with a 68.46% decline over the past year and a staggering 87.91% drop over three years. However, the stock has shown resilience over a five-year period, with a 74.05% increase, albeit underperforming the Sensex's 176.65% gain. Today's trading session opened with a gap up, and the intraday high reflects the strong buying momentum. The stock's current price is above its 5-day and 20-day moving averages, indicating short-term...

Read More

Vivanza Biosciences Ltd Sees Notable Buying Activity Amidst Mixed Long-Term Performance

2025-04-02 11:15:07

Vivanza Biosciences Ltd is currently witnessing significant buying activity, with the stock rising by 4.81% today, outperforming the Sensex, which gained only 0.64%. Over the past two days, Vivanza has recorded consecutive gains totaling 8.04%. Despite this recent uptick, the stock has faced challenges over longer periods, with a 1-month decline of 13.49% compared to the Sensex's 4.53% increase. The stock opened with a gap up, indicating strong initial buyer interest, and has shown resilience against broader market trends. While it remains above its 5-day moving average, it is still below the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a mixed performance in the context of longer-term trends. Factors contributing to the current buying pressure may include market sentiment shifts, potential news related to the company, or sector-specific developments. However, it is essential to note t...

Read More

Vivanza Biosciences Faces Challenges Amid Significant Stock Decline and Weak Fundamentals

2025-04-01 11:48:27

Vivanza Biosciences has reached a new 52-week low, continuing a six-day losing streak. The stock has underperformed significantly over the past year, with a 70.75% decline. Financial metrics indicate weak fundamentals, including low ROCE and high debt levels, alongside a notable reduction in promoter stake.

Read More

Vivanza Biosciences Hits 52-Week Low Amid Ongoing Financial Challenges and Stakeholder Concerns

2025-04-01 11:48:25

Vivanza Biosciences has reached a new 52-week low, reflecting a substantial decline over the past year. The company faces ongoing financial challenges, including negative net sales growth and a high debt-to-EBITDA ratio. Additionally, promoter confidence has decreased, indicating concerns about its market position and financial health.

Read More

Vivanza Biosciences Ltd Sees Notable Buying Activity Amidst Recent Price Volatility

2025-04-01 11:45:07

Vivanza Biosciences Ltd is currently witnessing significant buying activity, marking a notable performance shift after a series of declines. Today, the stock has increased by 4.52%, contrasting sharply with the Sensex, which has declined by 1.56%. This uptick comes after six consecutive days of falling prices, indicating a potential trend reversal. Despite this daily gain, Vivanza's performance over the past week shows a slight decline of 1.42%, while the Sensex has decreased by 2.32%. Over the past month, Vivanza has faced a more substantial drop of 17.46%, compared to the Sensex's increase of 4.11%. The stock has reached a new 52-week low of Rs. 1.9 today, highlighting the volatility in its recent performance. The buying pressure may be attributed to various factors, including market sentiment and potential interest in microcap stocks. However, Vivanza remains below its 5-day, 20-day, 50-day, 100-day, a...

Read More

Vivanza Biosciences Hits All-Time Low Amidst Ongoing Financial Challenges and Declining Stakeholder Confidence

2025-04-01 11:41:24

Vivanza Biosciences has reached a new 52-week low, despite a recent performance uptick. The stock has declined significantly over the past year, underperforming the market. Financial metrics indicate weak fundamentals, and promoter confidence is waning, with a notable reduction in stake ownership, highlighting ongoing challenges for the company.

Read More

Vivanza Biosciences Faces Major Financial Challenges Amidst Declining Stakeholder Confidence

2025-03-28 10:36:58

Vivanza Biosciences has faced considerable volatility, reaching a new 52-week low and experiencing a notable decline over the past four days. The company reported a significant drop in net sales and a low return on capital employed, alongside a concerning debt-to-EBITDA ratio. Promoter stake has also decreased, indicating waning confidence.

Read More

Vivanza Biosciences Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-28 10:35:15

Vivanza Biosciences Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past four days, resulting in a total loss of 7.44% during this period. Today, the stock fell by 1.97%, underperforming the Sensex, which saw a marginal increase of 0.01%. Over the past month, Vivanza Biosciences has recorded a staggering decline of 21.03%, while the Sensex gained 6.04%. The stock's performance has been consistently negative, with a year-to-date drop of 42.82% compared to the Sensex's slight decline of 0.67%. Notably, the stock has reached a new 52-week low of Rs. 1.99 today. The ongoing selling pressure may be attributed to various factors, including the stock's underperformance relative to the broader market and its trading position below key moving averages across multiple timeframes. Over the last three years, Vi...

Read More

Vivanza Biosciences Hits All-Time Low Amid Ongoing Financial Struggles and Volatility

2025-03-28 10:31:12

Vivanza Biosciences has faced notable volatility, hitting an all-time low and underperforming its sector. The stock has consistently declined over the past four days and is trading below key moving averages. Weak fundamentals and a significant reduction in promoter stake further highlight the company's challenges in the current market.

Read More

View All News